Clinical trial
The Association Between Myocardial Bridging and Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
NCT06598995 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Association Between Myocardial Bridging and Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- December 31, 2022
- Enrollment
- 968 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), myocardial bridging, obstructive hypertrophic cardiomyopathy